Cargando…

Rapamycin suppresses brain aging in senescence-accelerated OXYS rats

Cellular and organismal aging are driven in part by the MTOR (mechanistic target of rapamycin) pathway and rapamycin extends life span in C elegans, Drosophila and mice. Herein, we investigated effects of rapamycin on brain aging in OXYS rats. Previously we found, in OXYS rats, an early development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolosova, Nataliya G., Vitovtov, Anton O., Muraleva, Natalia A, Akulov, Andrey E., Stefanova, Natalia A., Blagosklonny, Mikhail V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824413/ https://www.ncbi.nlm.nih.gov/pubmed/23817674

Ejemplares similares

MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats
por: Muraleva, Natalia A., et al.
Publicado: (2021)

SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer’s Disease-Like Pathology in OXYS Rats
por: Muraleva, Natalia A., et al.
Publicado: (2020)

Single-Nucleotide Polymorphisms (SNPs) Both Associated with Hypertension and Contributing to Accelerated-Senescence Traits in OXYS Rats
por: Devyatkin, Vasiliy A., et al.
Publicado: (2020)

Quantitative trait loci on chromosome 1 for cataract and AMD-like retinopathy in senescence-accelerated OXYS rats
por: Korbolina, Elena E., et al.
Publicado: (2012)

Association of cerebrovascular dysfunction with the development of Alzheimer’s disease-like pathology in OXYS rats
por: Stefanova, Natalia A., et al.
Publicado: (2018)

Postnatal Maturation of the Blood–Brain Barrier in Senescence-Accelerated OXYS Rats, Which Are Prone to an Alzheimer’s Disease-like Pathology
por: Rudnitskaya, Ekaterina, et al.
Publicado: (2023)

The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats
por: Kolosova, Nataliya G., et al.
Publicado: (2012)

Rapamycin, proliferation and geroconversion to senescence
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Cell senescence, rapamycin and hyperfunction theory of aging
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats
por: Stefanova, Natalia A., et al.
Publicado: (2014)

Tryptophan and kynurenine levels in lenses of Wistar and accelerated-senescence OXYS rats
por: Snytnikova, Olga A., et al.
Publicado: (2009)

Alterations of retinal pigment epithelium cause AMD-like retinopathy in senescence-accelerated OXYS rats
por: Markovets, Anton M., et al.
Publicado: (2010)

While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts
por: Leontieva, Olga V., et al.
Publicado: (2017)

Calorie Restriction Provides Kidney Ischemic Tolerance in Senescence-Accelerated OXYS Rats
por: Andrianova, Nadezda V., et al.
Publicado: (2022)

The Rat Brain Transcriptome: From Infancy to Aging and Sporadic Alzheimer’s Disease-like Pathology
por: Stefanova, Natalia A., et al.
Publicado: (2023)

P38 MAPK Signaling in the Retina: Effects of Aging and Age-Related Macular Degeneration
por: Muraleva, Natalia A., et al.
Publicado: (2023)

Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the Accumulation of Amyloid β and in mTOR Activity
por: Muraleva, Natalia A., et al.
Publicado: (2019)

Delayed Formation of Neonatal Reflexes and of Locomotor Skills Is Associated with Poor Maternal Behavior in OXYS Rats Prone to Alzheimer’s Disease-like Pathology
por: Kozlova, Tatiana, et al.
Publicado: (2022)

An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology
por: Stefanova, Natalia A., et al.
Publicado: (2016)

Age-related changes in the water-soluble lens protein composition of Wistar and accelerated-senescence OXYS rats
por: Kopylova, Lyudmila V., et al.
Publicado: (2011)

Rapamycin for the aging skin
por: Blagosklonny, Mikhail V.
Publicado: (2019)

Cancer prevention with rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin
por: Leontieva, Olga V., et al.
Publicado: (2011)

Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study
por: Stefanova, Natalia A., et al.
Publicado: (2019)

Rapamycin for longevity: opinion article
por: Blagosklonny, Mikhail V.
Publicado: (2019)

Does rapamycin slow down time?
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Progeria, rapamycin and normal aging: recent breakthrough
por: Blagosklonny, Mikhail V.
Publicado: (2011)

Glia Not Neurons: Uncovering Brain Dysmaturation in a Rat Model of Alzheimer’s Disease
por: Rudnitskaya, Ekaterina A., et al.
Publicado: (2021)

Fasting and rapamycin: diabetes versus benevolent glucose intolerance
por: Blagosklonny, Mikhail V.
Publicado: (2019)

p62 /SQSTM1 coding plasmid prevents age related macular degeneration in a rat model
por: Kolosova, Nataliya G., et al.
Publicado: (2018)

Tumor suppression by p53 without apoptosis and senescence: conundrum or rapalog-like gerosuppression?
por: Blagosklonny, Mikhail V.
Publicado: (2012)

Rapamycin extends life- and health span because it slows aging
por: Blagosklonny, Mikhail V.
Publicado: (2013)

As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Application of quantitative trait locus mapping and transcriptomics to studies of the senescence-accelerated phenotype in rats
por: Korbolina, Elena E, et al.
Publicado: (2014)

Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
por: Blagosklonny, Mikhail V.
Publicado: (2012)

DNA- and telomere-damage does not limit lifespan: evidence from rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2021)

As predicted by hyperfunction theory, rapamycin treatment during development extends lifespan
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging
por: Leontieva, Olga V., et al.
Publicado: (2012)

Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice
por: Blagosklonny, Mikhail V.
Publicado: (2022)

Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression
por: Leontieva, Olga V., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m6up0sch9qgpgbjfmvqeg63kgv